Correlation Between Kodiak Sciences and Unicycive Therapeutics

Can any of the company-specific risk be diversified away by investing in both Kodiak Sciences and Unicycive Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Kodiak Sciences and Unicycive Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Kodiak Sciences and Unicycive Therapeutics, you can compare the effects of market volatilities on Kodiak Sciences and Unicycive Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Kodiak Sciences with a short position of Unicycive Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Kodiak Sciences and Unicycive Therapeutics.

Diversification Opportunities for Kodiak Sciences and Unicycive Therapeutics

0.85

Correlation Coefficient

Kodiak Sciences  Unicycive Therapeutics

Very poor diversification

The 3 months correlation between Kodiak and Unicycive is 0.85. Overlapping area represents the amount of risk that can be diversified away by holding Kodiak Sciences and Unicycive Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Unicycive Therapeutics and Kodiak Sciences is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Kodiak Sciences are associated (or correlated) with Unicycive Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Unicycive Therapeutics has no effect on the direction of Kodiak Sciences i.e., Kodiak Sciences and Unicycive Therapeutics go up and down completely randomly.

Pair Corralation between Kodiak Sciences and Unicycive Therapeutics

Considering the 90-day investment horizon Kodiak Sciences is expected to generate 0.75 times more return on investment than Unicycive Therapeutics. However, Kodiak Sciences is 1.34 times less risky than Unicycive Therapeutics. It trades about 0.41 of its potential returns per unit of risk. Unicycive Therapeutics is currently generating about 0.24 per unit of risk. If you would invest  242.00  in Kodiak Sciences on September 3, 2024 and sell it today you would earn a total of  425.00  from holding Kodiak Sciences or generate 175.62% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Strong
Accuracy	100.0%
Values	Daily Returns

Kodiak Sciences  vs.  Unicycive Therapeutics

Kodiak Sciences

Risk-Adjusted Performance

31 of 100

Very Strong

Compared to the overall equity markets, risk-adjusted returns on investments in Kodiak Sciences are ranked lower than 31 (%) of all global equities and portfolios over the last 90 days. In spite of rather abnormal basic indicators, Kodiak Sciences exhibited solid returns over the last few months and may actually be approaching a breakup point.

Unicycive Therapeutics

Risk-Adjusted Performance

19 of 100

Solid

Compared to the overall equity markets, risk-adjusted returns on investments in Unicycive Therapeutics are ranked lower than 19 (%) of all global equities and portfolios over the last 90 days. In spite of fairly weak fundamental indicators, Unicycive Therapeutics showed solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Kodiak Sciences and Unicycive Therapeutics

The main advantage of trading using opposite Kodiak Sciences and Unicycive Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Kodiak Sciences position performs unexpectedly, Unicycive Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Unicycive Therapeutics will offset losses from the drop in Unicycive Therapeutics' long position.

The idea behind Kodiak Sciences and Unicycive Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.